The firm owned 20,633 shares of the oil and gas company's stock after selling 1,155 shares during the period. Howard Hughes Medical Institute now holds 133,405 shares valued at $1,174,000.
Encana Corp (NYSE:ECA) shares traded -2.25% down during most recent session to reach at the closing price of $9.56. Quantitative Systematic Strategies LLC bought a new position in shares of Encana Corporation during the second quarter worth $118,000. Wellington Management Group LLP now owns 12,168,568 shares of the oil and gas company's stock valued at $142,337,000 after buying an additional 9,385,795 shares during the last quarter. Equity Investment Corp Acquisition Inc raised its stake in shares of Encana Corporation by 10.7% in the first quarter. CIBC Asset Management has an ownership of 6,575,705 stocks of the oil and gas firms shares valued $57,790,000 after scooping up an extra 3,131,997 stocks in the previous period. The share last price represents downtick move of -30.97% in value from company's 52-Week high price and shows 19.35% above change in value from its 52-Week low price.
Viking Global Investors Lp decreased Biogen Inc (NASDAQ:BIIB) stake by 267,524 shares to 1.92M valued at $544.14M in 2016Q4. BlackRock increased its position in Encana Corporation by 11,232.3% in the Q1. The value in dollars went from $18,060,000 to $5,973,000 a change of 66.9% since the last quarter. Institutional investors own 73.10% of the company's stock. Encana Corporation earned a news impact score of 0.19 on Accern's scale. The stock has a market cap of $9.43 billion, a price-to-earnings ratio of 11.55 and a beta of 2.04.
It is now trading at $9.70 slightly over the 50 day moving average which is $9.34 and significantly below the 200 day moving average of $10.68.
Encana Corporation (NYSE:ECA) (TSE:ECA) last released its quarterly earnings data on Friday, July 21st.
Encana Corp (NYSE:ECA)'s revenue estimates for the current quarter are $906.12 Million according to 5 number of analysts, for the current quarter the company has high revenue estimates of $1.02 Billion in contradiction of low revenue estimates of $798.16 Million.
EPS growth in past 5 year was -28.07% along with sales growth of -19.20% in the last five years. In the latest earnings report the EPS was $0.84 and is projected to be $0.50 for the current year with 973,095,000 shares outstanding. Stockholders of record on Friday, September 15th will be issued a $0.015 dividend. The dividend will be $0.015 per share for the quarter or $0.06 annualized. The ex-dividend date is Thursday, September 14th. The stock of Encana Corp (USA) (NYSE:ECA) has "Hold" rating given on Friday, March 31 by Desjardins Securities.
TRADEMARK VIOLATION NOTICE: This news story was originally published by Transcript Daily and is the sole property of of Transcript Daily. The correct version of this piece of content can be viewed at https://weekherald.com/2017/08/12/stratos-wealth-partners-ltd-has-182000-position-in-encana-corporation-nyseeca.html. UBS downgraded the shares of ECA in report on Tuesday, January 26 to "Neutral" rating. Canaccord Genuity restated a buy rating and issued a $14.00 target price on shares of Encana Corporation in a report on Tuesday, April 11th. Raymond James Financial, Inc. boosted their price objective on shares of Encana Corporation from $14.00 to $15.00 and gave the company a "strong-buy" rating in a report on Monday, July 24th.
Among 25 analysts covering CSX Corporation (NYSE:CSX), 17 have Buy rating, 1 Sell and 7 Hold. The stock presently has an average rating of "Buy" and a consensus target price of $13.32.
Encana Corporation is an energy producer that is focused on developing its multi-basin portfolio of natural gas, oil and natural gas liquids (NGLs) producing plays. The Company's activities also include the marketing of natural gas, oil and NGLs. All of its reserves and production are located in North America. KLR Group initiated Encana Corp (USA) (NYSE:ECA) on Monday, August 29 with "Hold" rating.